EZH2 and Miyoshi myopathy: demonstrated a significant negative correlation between CD38 and Enhancer of Zeste Homolog 2 (EZH2) expression; indeed, the inhibition of EZH2 upregulates CD38 on surface and increases ADCC both in HMCLs and primary MM cells (111).